Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Chan

Showing results (411-420 of 449) with videos related to

Pageof 45
Sort By:
Nature Communications|October 31, 2020
SARS-CoV-2 viral load is associated with increased disease severity and mortalityJesse Fajnzylber, James Regan, Kendyll Coxen, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Machine learning cross-platform proteomic imputation enables protein quality scoring and replication of epidemiological associationsLinke Li, Ahmed Alaa, Youxin Tan, et al.
Cells|January 16, 2020
The Rare <i>IL22RA2</i> Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple SclerosisPaloma Gómez-Fernández, Aitzkoa Lopez de Lapuente Portilla, Ianire Astobiza, et al.
Neurogenetics|March 19, 2014
Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosisChristina M Lill, Marcel Schilling, Sara Ansaloni, et al.
Neurology. Clinical Practice|July 7, 2025
Treatment Strategies and Disease Activity During Pregnancy and Postpartum: Real-World Data From the Swiss Multiple Sclerosis CohortMaximilian Einsiedler, Chiara Zecca, Lisa Hofer, et al.
Nature Biomedical Engineering|September 25, 2023
A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecovirusesSneha Vishwanath, George William Carnell, Matteo Ferrari, et al.
Journal of Neurology|July 2, 2025
Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis CohortAlessandro Cagol, Sabine Schaedelin, Mario Ocampo-Pineda, et al.
Annals of Neurology|May 31, 2021
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple SclerosisJohanna Oechtering, Sabine Schaedelin, Pascal Benkert, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 23, 2017
Quantifying the Genetic Correlation between Multiple Cancer TypesSara Lindström, Hilary Finucane, Brendan Bulik-Sullivan, et al.
The Journal of Infection|September 11, 2022
Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN studyAna Atti, Ferdinando Insalata, Edward J Carr, et al.
Pageof 45

Showing results (411-420 of 449) with videos related to

Sort By:
Pageof 45
Nature Communications|October 31, 2020
SARS-CoV-2 viral load is associated with increased disease severity and mortalityJesse Fajnzylber, James Regan, Kendyll Coxen, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Machine learning cross-platform proteomic imputation enables protein quality scoring and replication of epidemiological associationsLinke Li, Ahmed Alaa, Youxin Tan, et al.
Cells|January 16, 2020
The Rare <i>IL22RA2</i> Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple SclerosisPaloma Gómez-Fernández, Aitzkoa Lopez de Lapuente Portilla, Ianire Astobiza, et al.
Neurogenetics|March 19, 2014
Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosisChristina M Lill, Marcel Schilling, Sara Ansaloni, et al.
Neurology. Clinical Practice|July 7, 2025
Treatment Strategies and Disease Activity During Pregnancy and Postpartum: Real-World Data From the Swiss Multiple Sclerosis CohortMaximilian Einsiedler, Chiara Zecca, Lisa Hofer, et al.
Nature Biomedical Engineering|September 25, 2023
A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecovirusesSneha Vishwanath, George William Carnell, Matteo Ferrari, et al.
Journal of Neurology|July 2, 2025
Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis CohortAlessandro Cagol, Sabine Schaedelin, Mario Ocampo-Pineda, et al.
Annals of Neurology|May 31, 2021
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple SclerosisJohanna Oechtering, Sabine Schaedelin, Pascal Benkert, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 23, 2017
Quantifying the Genetic Correlation between Multiple Cancer TypesSara Lindström, Hilary Finucane, Brendan Bulik-Sullivan, et al.
The Journal of Infection|September 11, 2022
Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN studyAna Atti, Ferdinando Insalata, Edward J Carr, et al.
Pageof 45